about
msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentationT-cell clonotypes in cancerPhytochemicals for the Management of MelanomaAbnormal protein tyrosine kinase gene expression during melanoma progression and metastasisInduction of matrix metalloproteinase-1 (MMP-1) during epidermal invasion of the stroma in human skin organ culture: keratinocyte stimulation of fibroblast MMP-1 productionIncipient and overt stages of neoplastic transformationTranslation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cellsin vitroMetabotropic glutamate receptors (mGlus) and cellular transformation.Tumor progression, early diagnosis and prognosis of melanoma.The genetics of hereditary melanoma and nevi. 1998 update.Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents.CD40 stimulation accelerates deletion of tumor-specific CD8(+) T cells in the absence of tumor-antigen vaccination.Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression.The somatic mutation theory of cancer: growing problems with the paradigm?Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesisBoolean network model for cancer pathways: predicting carcinogenesis and targeted therapy outcomesCytokine therapeutics: lessons from interferon alphaACP best practice no 162. The histological reporting of melanoma. Association of Clinical PathologistsA novel role of myosin VI in human prostate cancerStrategies for skin cancer prevention.Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma.Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigmE-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine-resistant phenotype.Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes.Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.The role of B-RAF in melanoma.Emergentism as a default: cancer as a problem of tissue organization.Role of nuclear factor-kappa B in melanoma.Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery.NF-kappaB activation in melanoma.Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems.Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma.Adaptive evolution of degrees and kinds of neoplastic transformation in cell cultureEpigenetic regulation of the TRAIL/Apo2L apoptotic pathway by histone deacetylase inhibitors: an attractive approach to bypass melanoma immunotherapy resistanceCell cycle control and adhesion signaling pathways in the development of metastatic melanoma.Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression.Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.High rate of diversification and reversal among subclones of neoplastically transformed NIH 3T3 clones.
P2860
Q24318394-B24442CB-0193-42B0-98AA-11976E13447AQ24803891-DB87829C-93C4-4B8D-B49C-E638954B3EFAQ26766708-77AC3938-5126-45CB-86A7-7E7158F29BC6Q28305007-96EC4172-5855-4716-96E9-36AB2F0D28D8Q28364971-C4C1C0F7-66C2-4D35-8B25-21AC73F6C42AQ28385847-C2DF7501-6E47-4473-9B08-FCF711F0B2DAQ29013001-5D21091E-0646-48A2-980B-64208B317AA2Q30487265-CC6D2635-FA1E-4BC0-A8E5-9103383A0E40Q33700535-F2DE165E-C9B3-4B0B-93D4-A37D3A423208Q33813969-C37A4D7D-B961-4814-BAAB-4B3125009CB4Q33888325-2C4B69F0-8539-402A-8BF1-E66EB1CF5771Q33943864-1C0612D7-3837-4CFA-9C71-E49349BEBF67Q34084509-7B6C53A7-4E75-4CF3-9528-BB356B46CACBQ34350374-9D0F57D0-E3A8-4EFC-B5A4-47025D05957EQ34512415-FE188234-2B4E-453B-B6C0-D672D5233C77Q34901991-676A62E2-12EE-48E6-BE2F-B9753D74FA76Q35033232-25E69E6B-CD15-4FD4-9EFA-11786E093112Q35570999-C469E417-A27A-4F8F-9FAB-AAB13181C56EQ35607414-E9A3FFA7-27FC-479C-AD87-983623B733A2Q35748087-98F42BE1-63A4-496F-84EC-A21E1A6A4021Q35754547-C5003463-CB1C-4473-A8E0-56E40DAAF6A1Q35804856-C780E0B7-88E0-4670-B26C-DCE970D65AE2Q35810162-CEB0E492-DB11-4C45-8650-9C9607266FD1Q35833651-406B6359-75D5-4368-9BAD-5685AEDBC8A1Q35833837-7B6E809E-A606-432F-A366-262E2C7097B4Q35889074-1758CDCC-F6CC-42B9-85BA-CF4833464CDEQ36078119-DF44C437-E0D3-4ED9-8EA0-25BBF1F35814Q36095615-4F28A9C1-3EEC-41DA-A601-779A6EABEE4CQ36178379-6FA0628F-44E2-4A56-813D-09E594AEAEBCQ36233022-F9DDC238-2A09-45B0-B453-3C21EB9135A4Q36395752-760B869F-3401-4763-A6D4-5B2F8B8B7C4AQ36416479-4F5894B3-994A-472B-AB79-F0AFAC69266AQ36495546-C71387AA-414D-4532-A571-4D74CBE0CC63Q36701474-D2C82CA7-955A-486E-916B-3FD348C6CD45Q36812946-D14F4C69-F6D0-403E-A868-FDB280F9A396Q37021699-814E86C8-B2B7-4C33-92B3-23D2F6C74B73Q37170360-B68C1306-EA42-4E9C-ADD5-BF1FD176DBC5Q37228532-E68E99BB-E945-4E81-B61D-F69EB2ACD451Q37341182-69B1FBF2-B3B7-4151-9DD9-4D578CAE0BE4Q37600337-F9FD13D8-7CB7-4BBC-B7BA-FD32597F454B
P2860
description
1991 nî lūn-bûn
@nan
1991 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
name
Tumour progression and the nature of cancer
@ast
Tumour progression and the nature of cancer
@en
Tumour progression and the nature of cancer
@nl
type
label
Tumour progression and the nature of cancer
@ast
Tumour progression and the nature of cancer
@en
Tumour progression and the nature of cancer
@nl
prefLabel
Tumour progression and the nature of cancer
@ast
Tumour progression and the nature of cancer
@en
Tumour progression and the nature of cancer
@nl
P2860
P3181
P356
P1476
Tumour progression and the nature of cancer
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/BJC.1991.375
P407
P577
1991-10-01T00:00:00Z
P5875
P6179
1023329524